Related Experiment Video
Updated: Apr 27, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Complete congenital foetal heart block: a case report
M Dey1, T Jose1, A Shrivastava1
1Department of Obstetrics and Gynaecology, Armed Forces Medical College, Pune, Maharashtra, India - 411040.
Insights
Congenital heart block (CHB), a severe neonatal lupus complication, can lead to lethal atrioventricular (AV) block. This case highlights a favorable outcome in fetal complete CHB associated with high maternal anti-Ro/SSA and anti-La/SSB antibody titers.
Area of Science:
- Immunology
- Cardiology
- Neonatology
Background:
- Congenital heart block (CHB) is the most severe manifestation of neonatal lupus.
- It can progress to a lethal atrioventricular (AV) block, typically developing between 20-24 weeks gestation.
- CHB in fetuses with structurally normal hearts is often linked to maternal autoantibodies, specifically anti-Ro/SSA and anti-La/SSB.
Observation:
- This report details a case of fetal complete CHB.
- The case involved a mother with high titers of anti-Ro/SSA and anti-La/SSB autoantibodies.
- The fetal outcome was favorable despite the high antibody levels.
Findings:
- Maternal autoantibodies (anti-Ro/SSA and anti-La/SSB) are strongly associated with CHB.
- High titers of these antibodies were present in the reported case.
- Successful management or natural resolution led to a favorable fetal outcome.
Implications:
- This case suggests that even with high maternal autoantibody titers, a favorable outcome for fetal CHB is possible.
- It underscores the importance of monitoring and potentially managing pregnancies with maternal autoantibodies.
- Further research into the mechanisms and management of CHB in neonatal lupus is warranted.
Abstract:
Congenital heart block (CHB) is the most severe manifestation of neonatal lupus which can develop into a lethal atrioventricular (AV) block. Complete congenital foetal heart block related to maternal anti-Ro/SSA autoanti-bodies typically develops between 20 and 24 weeks of gestation. CHB with a structurally normal heart is frequently associated with maternal autoantibodies to Ro/SSA and La/SSB. We are presenting a case of foetal complete CHB with high maternal Ro/SSA and La/SSB titre with favourable outcome.
Related Concept Videos
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Fetal Circulation
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Mitral Stenosis I: Introduction
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiomyopathy I: Introduction and Classification

